HIG.TO Brompton Global Healthcare Income & Growth ETF
This actively managed fund aims to provide consistent monthly income, capital appreciation, and reduced volatility. It achieves these goals by investing in a concentrated portfolio of 15 to 30 large, international healthcare companies that exhibit both strong value and growth characteristics. Companies are rigorously assessed beyond their market capitalization, with a focus on their valuation, growth prospects, profitability, liquidity, balance sheet strength, and dividend yield. Up to a quarter of the fund's assets may also be allocated to other healthcare-related businesses, provided they meet specific size requirements. To further enhance returns and temper overall portfolio risk, the fund manager strategically sells call options. This particular fund is an unhedged counterpart to HIG, with its units traded in U.S. dollars.
Performance
| 1M | 3M | YTD | 1Y | 3Y ann. | 5Y ann. | |
|---|---|---|---|---|---|---|
| HIG.TO | +7.6% | +9.9% | +9.2% | +8.4% | +9.2% | +1.8% |
| Equity average (1460 funds) | -5.4% | -4.7% | +1.4% | +3.9% | +11.9% | +4.6% |
Insider activity in the holdings
Open-market insider buying across this fund’s holdings over 90 days, weighted by holding weight: +$38K net.
| Holding | Weight | Insiders bought | Insiders sold |
|---|---|---|---|
| CVS CVS Health Corporation | 1.90% | $2.0M | $0 |
Holdings · as of Nov 15, 2026
| # | Holding | Weight |
|---|---|---|
| 1 | LLY Eli Lilly and Company | 6.10% |
| 2 | GILD Gilead Sciences, Inc. | 6.00% |
| 3 | NVS Novartis AG ADR | 5.50% |
| 4 | JNJ Johnson & Johnson | 5.50% |
| 5 | HIG.TO Others | 5.20% |
| 6 | VRTX Vertex Pharmaceuticals Incorporated | 4.90% |
| 7 | MCK McKesson Corp. | 4.80% |
| 8 | MRK Merck & Co Inc. | 4.80% |
| 9 | CAH Cardinal Health, Inc. | 4.60% |
| 10 | UNH UnitedHealth Group Incorporated | 4.60% |
| 11 | HCA HCA Healthcare, Inc. | 4.50% |
| 12 | A Agilent Technologies Inc. | 4.40% |
| 13 | DHR Danaher Corporation | 3.90% |
| 14 | CI The Cigna Group | 3.80% |
| 15 | TMO Thermo Fisher Scientific Inc. | 3.70% |
| 16 | EW Edwards Lifesciences Corporation | 3.10% |
| 17 | AMGN Amgen Inc. | 3.00% |
| 18 | REGN Regeneron Pharmaceuticals, Inc. | 2.80% |
| 19 | AZN AstraZeneca PLC ADR | 2.80% |
| 20 | DGX Quest Diagnostics Inc. | 2.80% |
| 21 | BMY Bristol-Myers Squibb Company | 2.70% |
| 22 | GSK GSK PLC ADR | 2.60% |
| 23 | RO.SW Roche Holding AG | 2.10% |
| 24 | ISRG Intuitive Surgical, Inc. | 2.00% |
| 25 | WAT Waters Corp. | 1.90% |
| 26 | CVS CVS Health Corporation | 1.90% |
Sector breakdown
Country breakdown
Distributions
| Date | Per unit |
|---|---|
| Dec 31, 2026 | C$0.0400 |
| Nov 30, 2026 | C$0.0400 |
| Oct 30, 2026 | C$0.0400 |
| Sep 29, 2026 | C$0.0550 |
| Aug 31, 2026 | C$0.0550 |
| Jul 31, 2026 | C$0.0550 |
| Jun 30, 2026 | C$0.0550 |
| May 29, 2026 | C$0.0550 |
| Apr 30, 2026 | C$0.0550 |
| Mar 31, 2026 | C$0.0550 |
| Feb 27, 2026 | C$0.0550 |
| Jan 30, 2026 | C$0.0550 |
| Dec 31, 2025 | C$0.0550 |
| Nov 28, 2025 | C$0.0550 |
| Oct 31, 2025 | C$0.0550 |
| Sep 29, 2025 | C$0.0550 |
| Aug 29, 2025 | C$0.0550 |
| Jul 31, 2025 | C$0.0550 |
| Jun 30, 2025 | C$0.0550 |
| May 30, 2025 | C$0.0550 |
| Apr 30, 2025 | C$0.0550 |
| Mar 31, 2025 | C$0.0550 |
| Feb 28, 2025 | C$0.0550 |
| Jan 31, 2025 | C$0.0550 |
| Dec 31, 2024 | C$0.0550 |
| Nov 29, 2024 | C$0.0550 |
| Oct 31, 2024 | C$0.0550 |
| Sep 27, 2024 | C$0.0550 |
| Aug 30, 2024 | C$0.0550 |
| Jul 31, 2024 | C$0.0550 |
| Jun 28, 2024 | C$0.0550 |
| May 31, 2024 | C$0.0550 |
| Apr 29, 2024 | C$0.0550 |
| Mar 27, 2024 | C$0.0550 |
| Feb 28, 2024 | C$0.0550 |
| Jan 30, 2024 | C$0.0550 |
| Dec 28, 2023 | C$0.0550 |
| Nov 29, 2023 | C$0.0550 |
| Oct 30, 2023 | C$0.0550 |
| Sep 28, 2023 | C$0.0550 |
Members of Congress who disclosed this ETF
No member of Congress has disclosed a trade in HIG.TO in the filings we hold.
Fund facts, prices, performance and distributions: our market-data vendor. Holdings: the vendor and SEC Form N-PORT. Insider and Congress data: InsiderBuying. Last updated Nov 16, 2026. This is historical data, not investment advice. Report a data error
